UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1466-1472

2015

Volltextzugriff (PDF)

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0233918-e0233918

2023

Volltextzugriff (PDF)

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients

Diabetes & metabolism, 2019-12, Vol.45 (6), p.573-581

2019

Volltextzugriff (PDF)

Review of trials currently testing treatment and prevention of COVID-19

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.988-998

2020

Volltextzugriff (PDF)

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Two levels of specialization in bacteraemic Escherichia coli strains revealed by their comparison with commensal strains

Epidemiology and infection, 2017-04, Vol.145 (5), p.872-882

2017

Volltextzugriff (PDF)

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Clinical microbiology and infection, 2011-04, Vol.17 (4), p.557-565

2011

Volltextzugriff (PDF)

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Journal of antimicrobial chemotherapy, 2020-08, Vol.75 (8), p.2334-2343

2020

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Reconstructing social interactions using an unreliable wireless sensor network

Computer communications, 2011-04, Vol.34 (5), p.609-618

2011

Volltextzugriff (PDF)

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3611-3618

2020

Volltextzugriff (PDF)

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Clinical pharmacology and therapeutics, 2012-11, Vol.92 (5), p.575-583

2012

Volltextzugriff (PDF)

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

British journal of cancer, 2013-09, Vol.109 (5), p.1147-1156

2013

Volltextzugriff (PDF)

Role of modelling and simulation in Phase I drug development

European journal of pharmaceutical sciences, 2001-05, Vol.13 (2), p.115-122

2001

Volltextzugriff (PDF)

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Antimicrobial agents and chemotherapy, 2014-05, Vol.58 (5), p.2681-2687

2014

Volltextzugriff (PDF)

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Computer methods and programs in biomedicine, 2001-05, Vol.65 (2), p.141-151

2001

Volltextzugriff (PDF)

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

Colorectal disease, 2016-10, Vol.18 (10), p.997-1004

2016

Volltextzugriff (PDF)

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Clinical microbiology and infection, 2019-05, Vol.25 (5), p.631.e1-631.e9

2019

Volltextzugriff (PDF)

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1035-O1041

2014

Volltextzugriff (PDF)

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia

European journal of clinical pharmacology, 2015-01, Vol.71 (1), p.75-83

2015

Volltextzugriff (PDF)

Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths

Science immunology, 2021-08, Vol.6 (62)

2021

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

CPT: pharmacometrics and systems pharmacology, 2014-12, Vol.3 (12), p.1-4

Mentré, F

2014

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

PublikationsformReviews

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(243)

Publikationsform

Artikel
(273)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients

Review of trials currently testing treatment and prevention of COVID-19

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Two levels of specialization in bacteraemic Escherichia coli strains revealed by their comparison with commensal strains

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Reconstructing social interactions using an unreliable wireless sensor network

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

Role of modelling and simulation in Phase I drug development

The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients

High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia

Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths

The ISoP Standards and Best Practices Committee

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

Aktive Filter

Suchergebnisse filtern